| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 KIF23 DDX12P MYH13 ATRX MYO1E DYNC2H1 ABCA13 KIF16B UBA2 NLRP1 XRCC5 DDX11 KIF15 SHOC1 MYH15 DSCC1 HSPA1A HSPA1B DNAH6 ATP6V0A2 | 2.19e-11 | 614 | 111 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 KIF23 DDX12P ATRX MYO1E DYNC2H1 ABCA13 KIF16B NLRP1 XRCC5 DDX11 KIF15 SHOC1 HSPA1A HSPA1B DNAH6 | 2.92e-09 | 441 | 111 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.11e-07 | 118 | 111 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA1 KIF23 DDX12P ATRX MYO1E DYNC2H1 ABCA13 KIF16B NLRP1 XRCC5 DDX11 KIF15 DCP1B SHOC1 GNAS HSPA1A HSPA1B DNAH6 | 8.35e-07 | 839 | 111 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA1 KIF23 DDX12P ATRX MYO1E DYNC2H1 ABCA13 KIF16B NLRP1 XRCC5 DDX11 KIF15 DCP1B SHOC1 GNAS HSPA1A HSPA1B DNAH6 | 8.50e-07 | 840 | 111 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA1 KIF23 DDX12P ATRX MYO1E DYNC2H1 ABCA13 KIF16B NLRP1 XRCC5 DDX11 KIF15 DCP1B SHOC1 GNAS HSPA1A HSPA1B DNAH6 | 8.50e-07 | 840 | 111 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA1 KIF23 DDX12P ATRX MYO1E DYNC2H1 ABCA13 KIF16B NLRP1 XRCC5 DDX11 KIF15 SHOC1 GNAS HSPA1A HSPA1B DNAH6 | 1.29e-06 | 775 | 111 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 1.37e-05 | 9 | 111 | 3 | GO:0017151 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.40e-05 | 70 | 111 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | denatured protein binding | 9.15e-05 | 3 | 111 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 1.06e-04 | 84 | 111 | 5 | GO:0003684 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 1.07e-04 | 17 | 111 | 3 | GO:0070411 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.09e-04 | 262 | 111 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | RBBP8 DTX3L CCDC62 PRKDC HSPA1A HSPA1B CNOT1 TP53BP1 SMAD3 RAD23B | 1.12e-04 | 417 | 111 | 10 | GO:0061629 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KRT2 KIF23 MYH13 MYO1E PSG1 SYNE1 TTLL5 CEP290 KIF16B SPTBN5 DST KIF15 SYNE2 MYH15 RP1 DIAPH3 GNAS | 1.17e-04 | 1099 | 111 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | triplex DNA binding | 1.82e-04 | 4 | 111 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 3.03e-04 | 5 | 111 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 3.03e-04 | 5 | 111 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 3.94e-04 | 62 | 111 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 4.53e-04 | 6 | 111 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 4.53e-04 | 6 | 111 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | histone kinase activity | 4.95e-04 | 28 | 111 | 3 | GO:0035173 | |
| GeneOntologyMolecularFunction | tubulin binding | 6.46e-04 | 428 | 111 | 9 | GO:0015631 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 7.20e-04 | 127 | 111 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 8.78e-04 | 358 | 111 | 8 | GO:0044389 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 9.40e-04 | 78 | 111 | 4 | GO:0003725 | |
| GeneOntologyMolecularFunction | phospholipid binding | 9.64e-04 | 548 | 111 | 10 | GO:0005543 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.13e-03 | 37 | 111 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.22e-03 | 38 | 111 | 3 | GO:0000146 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.35e-03 | 86 | 111 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | actin binding | 1.42e-03 | 479 | 111 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | RBBP8 DTX3L CCDC62 PRKDC HSPA1A HSPA1B CNOT1 TP53BP1 SMAD3 RAD23B | 1.51e-03 | 582 | 111 | 10 | GO:0140297 |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 1.63e-03 | 11 | 111 | 2 | GO:0043139 | |
| GeneOntologyMolecularFunction | U3 snoRNA binding | 1.63e-03 | 11 | 111 | 2 | GO:0034511 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.68e-03 | 308 | 111 | 7 | GO:0008017 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.75e-03 | 43 | 111 | 3 | GO:0030280 | |
| GeneOntologyMolecularFunction | helicase activity | 1.90e-03 | 158 | 111 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.94e-03 | 316 | 111 | 7 | GO:0035091 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 1.95e-03 | 12 | 111 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 2.00e-03 | 45 | 111 | 3 | GO:0043495 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 2.27e-03 | 47 | 111 | 3 | GO:0051539 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 2.67e-03 | 14 | 111 | 2 | GO:0051880 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 2.78e-03 | 337 | 111 | 7 | GO:0031625 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 2.82e-03 | 173 | 111 | 5 | GO:0070851 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 3.07e-03 | 15 | 111 | 2 | GO:0140776 | |
| GeneOntologyMolecularFunction | transcription factor binding | RBBP8 UBA2 DTX3L CCDC62 PRKDC HSPA1A HSPA1B CNOT1 TP53BP1 SMAD3 RAD23B | 3.15e-03 | 753 | 111 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 3.94e-03 | 17 | 111 | 2 | GO:0008574 | |
| GeneOntologyMolecularFunction | DNA replication origin binding | 4.42e-03 | 18 | 111 | 2 | GO:0003688 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 4.42e-03 | 18 | 111 | 2 | GO:0051787 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.42e-03 | 18 | 111 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | lamin binding | 4.92e-03 | 19 | 111 | 2 | GO:0005521 | |
| GeneOntologyMolecularFunction | proteasome binding | 5.45e-03 | 20 | 111 | 2 | GO:0070628 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein binding | 5.69e-03 | 128 | 111 | 4 | GO:0032182 | |
| GeneOntologyBiologicalProcess | microtubule-based process | SLK KIF23 ATRX DYNC2H1 TTLL5 PARP3 CEP290 KIF16B APOB DST CEP120 KIF15 SYNE2 RP1 DIAPH3 LZTS2 HSPA1A HSPA1B DNAH6 INPP5J PCNT | 1.61e-07 | 1058 | 110 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | SLK KIF23 ATRX TTLL5 PARP3 CEP290 DST CEP120 KIF15 SYNE2 RP1 DIAPH3 LZTS2 HSPA1A HSPA1B INPP5J PCNT | 2.62e-07 | 720 | 110 | 17 | GO:0000226 |
| GeneOntologyBiologicalProcess | spindle organization | 3.21e-06 | 224 | 110 | 9 | GO:0007051 | |
| GeneOntologyBiologicalProcess | DNA repair | DDX12P ATRX RBBP8 PARP3 DTX3L REV3L XRCC5 DDX11 DCLRE1A PRKDC HSPA1A HSPA1B TP53BP1 RAD23B | 9.05e-06 | 648 | 110 | 14 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA damage response | FNIP2 DDX12P ATRX DCUN1D5 RBBP6 RBBP8 PARP3 DTX3L REV3L XRCC5 DDX11 DCLRE1A PRKDC HSPA1A HSPA1B TP53BP1 RAD23B | 1.26e-05 | 959 | 110 | 17 | GO:0006974 |
| GeneOntologyBiologicalProcess | chromosome organization | KIF23 DDX12P ATRX PARP3 XRCC5 DDX11 KIF15 SHOC1 SGO2 PRKDC DSCC1 HSPA1A HSPA1B ANAPC5 | 1.71e-05 | 686 | 110 | 14 | GO:0051276 |
| GeneOntologyBiologicalProcess | post-embryonic animal morphogenesis | 1.72e-05 | 10 | 110 | 3 | GO:0009886 | |
| GeneOntologyBiologicalProcess | cell cycle process | KIF23 DDX12P CACUL1 ATRX RBBP8 PARP3 DTX3L DDX11 CEP120 KIF15 SHOC1 SGO2 PRKDC DIAPH3 LZTS2 DSCC1 HSPA1A HSPA1B ANAPC5 TP53BP1 PCNT | 2.14e-05 | 1441 | 110 | 21 | GO:0022402 |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 2.92e-05 | 67 | 110 | 5 | GO:0007062 | |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 3.14e-05 | 12 | 110 | 3 | GO:0090084 | |
| GeneOntologyBiologicalProcess | intracellular transport | ABCA1 DYNC2H1 SYNE1 CEP290 KIF16B DTX3L C2CD5 SPTBN5 RANBP17 DST CEP120 RANBP3L SYNE2 DIAPH3 GNAS LZTS2 HSPA1A HSPA1B SNX2 SMAD3 PCNT | 3.72e-05 | 1496 | 110 | 21 | GO:0046907 |
| GeneOntologyBiologicalProcess | maintenance of sister chromatid cohesion | 5.15e-05 | 14 | 110 | 3 | GO:0034086 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | FNIP2 ABCA1 SLK SYNE1 ADGRB3 CASP5 XRCC5 SPTBN5 CEP120 SACS SYNE2 RP1 FLRT2 HSPA1A HSPA1B CNOT1 INPP5J SMAD3 | 5.55e-05 | 1189 | 110 | 18 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | ATRX XRCC5 C2CD5 DDX11 CEP120 SGO2 RP1 HSPA1A HSPA1B ANAPC5 CNOT1 SMAD3 | 5.67e-05 | 574 | 110 | 12 | GO:0010638 |
| GeneOntologyBiologicalProcess | double-strand break repair via nonhomologous end joining | 5.73e-05 | 77 | 110 | 5 | GO:0006303 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | DDX12P ATRX RBBP6 RBBP8 PARP3 DTX3L REV3L XRCC5 DDX11 SHOC1 DCLRE1A PRKDC DSCC1 HSPA1A HSPA1B TP53BP1 RAD23B | 5.74e-05 | 1081 | 110 | 17 | GO:0006259 |
| GeneOntologyBiologicalProcess | double-strand break repair | 6.03e-05 | 324 | 110 | 9 | GO:0006302 | |
| GeneOntologyBiologicalProcess | embryo development | MYO1E RBBP6 DYNC2H1 RBBP8 CEP290 KIF16B APOB ITGA5 CCDC62 N4BP2L2 PRKDC DIAPH3 GNAS IL3 CNOT1 SMAD1 SMAD3 SMAD5 PCNT RAD23B | 6.61e-05 | 1437 | 110 | 20 | GO:0009790 |
| GeneOntologyBiologicalProcess | cytoplasmic pattern recognition receptor signaling pathway | 6.74e-05 | 188 | 110 | 7 | GO:0002753 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid cell differentiation | 8.28e-05 | 134 | 110 | 6 | GO:0045639 | |
| GeneOntologyBiologicalProcess | cytosolic small ribosomal subunit assembly | 8.43e-05 | 3 | 110 | 2 | GO:0180025 | |
| GeneOntologyBiologicalProcess | small-subunit processome assembly | 8.43e-05 | 3 | 110 | 2 | GO:0034462 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | FNIP2 ABCA1 ATRX ABCA13 SYNE1 ADGRB3 CASP5 XRCC5 C2CD5 DDX11 CEP120 SGO2 RP1 FLRT2 HSPA1A HSPA1B ANAPC5 CNOT1 SMAD3 | 1.04e-04 | 1366 | 110 | 19 | GO:0051130 |
| GeneOntologyBiologicalProcess | organelle assembly | KIF23 DYNC2H1 SYNE1 TTLL5 CEP290 XRCC5 CEP120 KIF15 SYNE2 RP1 PRKDC DIAPH3 LZTS2 HSPA1A HSPA1B CNOT1 PCNT | 1.08e-04 | 1138 | 110 | 17 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of sister chromatid cohesion | 1.57e-04 | 20 | 110 | 3 | GO:0007063 | |
| GeneOntologyBiologicalProcess | mitotic spindle organization | 1.60e-04 | 151 | 110 | 6 | GO:0007052 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | KIF23 ATRX RBBP8 PARP3 DTX3L DDX11 CEP120 SGO2 PRKDC DIAPH3 HSPA1A HSPA1B ANAPC5 TP53BP1 | 1.61e-04 | 845 | 110 | 14 | GO:0010564 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT1 KRT2 SLK MYO1E CASP5 SPTBN5 CEP120 LOXL2 KRT77 RP1 DIAPH3 HSPA1A HSPA1B INPP5J SMAD3 | 1.70e-04 | 957 | 110 | 15 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 1.83e-04 | 21 | 110 | 3 | GO:0090083 | |
| GeneOntologyBiologicalProcess | regulation of nuclease activity | 2.11e-04 | 22 | 110 | 3 | GO:0032069 | |
| GeneOntologyBiologicalProcess | innate immune response | KRT1 SLK PSG1 KIF16B CASP5 OAS3 NLRP1 TRIM43 DTX3L XRCC5 ITGAM TRIM43B COLEC12 PRKDC HSPA1A HSPA1B | 2.18e-04 | 1092 | 110 | 16 | GO:0045087 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | KIF23 XRCC5 CEP120 KIF15 PRKDC DIAPH3 LZTS2 HSPA1A HSPA1B CNOT1 | 2.29e-04 | 475 | 110 | 10 | GO:0140694 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ATRX SYNE1 PARP3 XRCC5 C2CD5 DDX11 SPTBN5 CEP120 SYNE2 SGO2 RP1 DIAPH3 HSPA1A HSPA1B ANAPC5 CNOT1 INPP5J SMAD3 | 2.54e-04 | 1342 | 110 | 18 | GO:0033043 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | FNIP2 ABCA1 ADGRB3 CASP5 CEP120 RP1 FLRT2 HSPA1A HSPA1B CNOT1 SMAD3 | 2.81e-04 | 582 | 110 | 11 | GO:0044089 |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 2.84e-04 | 108 | 110 | 5 | GO:0031110 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 2.84e-04 | 168 | 110 | 6 | GO:0000723 | |
| GeneOntologyBiologicalProcess | myeloid cell homeostasis | 3.05e-04 | 240 | 110 | 7 | GO:0002262 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 3.65e-04 | 176 | 110 | 6 | GO:0070507 | |
| GeneOntologyBiologicalProcess | microtubule polymerization | 4.11e-04 | 117 | 110 | 5 | GO:0046785 | |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 4.17e-04 | 6 | 110 | 2 | GO:0070370 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclease activity | 4.17e-04 | 6 | 110 | 2 | GO:0032075 | |
| GeneOntologyBiologicalProcess | osteoblast fate commitment | 4.17e-04 | 6 | 110 | 2 | GO:0002051 | |
| GeneOntologyBiologicalProcess | activation of innate immune response | 4.17e-04 | 333 | 110 | 8 | GO:0002218 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in mitosis | 5.03e-04 | 187 | 110 | 6 | GO:1902850 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 5.36e-04 | 124 | 110 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | heat acclimation | 5.82e-04 | 7 | 110 | 2 | GO:0010286 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 5.82e-04 | 7 | 110 | 2 | GO:0070434 | |
| GeneOntologyBiologicalProcess | receptor catabolic process | 5.95e-04 | 31 | 110 | 3 | GO:0032801 | |
| GeneOntologyBiologicalProcess | telomere organization | 6.97e-04 | 199 | 110 | 6 | GO:0032200 | |
| GeneOntologyBiologicalProcess | inclusion body assembly | 7.17e-04 | 33 | 110 | 3 | GO:0070841 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 7.63e-04 | 280 | 110 | 7 | GO:1902115 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 7.73e-04 | 8 | 110 | 2 | GO:0090063 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 7.73e-04 | 8 | 110 | 2 | GO:0070426 | |
| GeneOntologyBiologicalProcess | nuclear migration | 7.83e-04 | 34 | 110 | 3 | GO:0007097 | |
| GeneOntologyBiologicalProcess | post-embryonic development | 7.88e-04 | 135 | 110 | 5 | GO:0009791 | |
| GeneOntologyBiologicalProcess | DNA duplex unwinding | 8.06e-04 | 78 | 110 | 4 | GO:0032508 | |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | 8.07e-04 | 558 | 110 | 10 | GO:0030099 | |
| GeneOntologyBiologicalProcess | positive regulation of protein targeting to membrane | 8.53e-04 | 35 | 110 | 3 | GO:0090314 | |
| GeneOntologyBiologicalProcess | kidney development | 8.61e-04 | 372 | 110 | 8 | GO:0001822 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 8.66e-04 | 465 | 110 | 9 | GO:0007059 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 8.99e-04 | 288 | 110 | 7 | GO:0045637 | |
| GeneOntologyBiologicalProcess | positive regulation of cartilage development | 9.27e-04 | 36 | 110 | 3 | GO:0061036 | |
| GeneOntologyBiologicalProcess | receptor metabolic process | 9.73e-04 | 82 | 110 | 4 | GO:0043112 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 9.94e-04 | 293 | 110 | 7 | GO:0032886 | |
| GeneOntologyBiologicalProcess | positive regulation of erythrocyte differentiation | 1.00e-03 | 37 | 110 | 3 | GO:0045648 | |
| GeneOntologyBiologicalProcess | pattern recognition receptor signaling pathway | 1.01e-03 | 294 | 110 | 7 | GO:0002221 | |
| GeneOntologyBiologicalProcess | renal system development | 1.09e-03 | 386 | 110 | 8 | GO:0072001 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | CACUL1 PSG1 NLRP1 GRIN2A XRCC5 ITGAM RSU1 DDX11 DCP1B GNAS DSCC1 HSPA1A IL3 SMAD3 | 1.13e-03 | 1028 | 110 | 14 | GO:0043085 |
| GeneOntologyBiologicalProcess | DNA geometric change | 1.16e-03 | 86 | 110 | 4 | GO:0032392 | |
| GeneOntologyBiologicalProcess | cytosolic ribosome assembly | 1.23e-03 | 10 | 110 | 2 | GO:0042256 | |
| GeneOntologyBiologicalProcess | regulation of maintenance of sister chromatid cohesion | 1.23e-03 | 10 | 110 | 2 | GO:0034091 | |
| GeneOntologyBiologicalProcess | regulation of ribonuclease activity | 1.23e-03 | 10 | 110 | 2 | GO:0060700 | |
| GeneOntologyBiologicalProcess | defense response to symbiont | KRT1 SLK PSG1 KIF16B CASP5 OAS3 NLRP1 TRIM43 DTX3L XRCC5 ITGAM TRIM43B COLEC12 PRKDC HSPA1A HSPA1B | 1.29e-03 | 1286 | 110 | 16 | GO:0140546 |
| GeneOntologyBiologicalProcess | microtubule-based movement | 1.30e-03 | 493 | 110 | 9 | GO:0007018 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | MYO1E RBBP6 RBBP8 APOB CCDC62 N4BP2L2 DIAPH3 CNOT1 SMAD3 PCNT | 1.33e-03 | 596 | 110 | 10 | GO:0001701 |
| GeneOntologyBiologicalProcess | spindle assembly | 1.38e-03 | 153 | 110 | 5 | GO:0051225 | |
| GeneOntologyBiologicalProcess | DNA replication | 1.43e-03 | 312 | 110 | 7 | GO:0006260 | |
| GeneOntologyBiologicalProcess | innate immune response-activating signaling pathway | 1.43e-03 | 312 | 110 | 7 | GO:0002758 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 1.43e-03 | 403 | 110 | 8 | GO:1904951 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | CACUL1 PSG1 NLRP1 DTX3L GRIN2A XRCC5 ITGAM RSU1 DDX11 DCP1B GNAS DSCC1 HSPA1A HSPA1B IL3 TP53BP1 SMAD3 | 1.47e-03 | 1430 | 110 | 17 | GO:0044093 |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 1.49e-03 | 92 | 110 | 4 | GO:0090307 | |
| GeneOntologyBiologicalProcess | positive regulation of sister chromatid cohesion | 1.50e-03 | 11 | 110 | 2 | GO:0045876 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.50e-03 | 11 | 110 | 2 | GO:0070432 | |
| GeneOntologyBiologicalProcess | cellular response to X-ray | 1.50e-03 | 11 | 110 | 2 | GO:0071481 | |
| GeneOntologyBiologicalProcess | establishment of sister chromatid cohesion | 1.50e-03 | 11 | 110 | 2 | GO:0034085 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT1 KRT2 KIF23 MYH13 EFCAB6 DYNC2H1 SYNE1 TTLL5 KIF16B NARF CTPS2 DST KIF15 KRT77 SYNE2 MYH15 RP1 DIAPH3 LZTS2 DNAH6 HOMER1 PCNT | 1.52e-07 | 1179 | 109 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT1 KRT2 KIF23 MYH13 EFCAB6 DYNC2H1 SYNE1 TTLL5 KIF16B NARF CTPS2 DST KIF15 KRT77 SYNE2 MYH15 RP1 DIAPH3 LZTS2 DNAH6 HOMER1 PCNT | 1.71e-07 | 1187 | 109 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | centrosome | FNIP2 KIF23 DDX12P RBBP6 TTLL5 PARP3 CEP290 TRIM43 C2CD5 DDX11 CEP120 KIF15 LZTS2 HSPA1A HSPA1B PCNT | 2.40e-06 | 770 | 109 | 16 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | FNIP2 KIF23 DDX12P RBBP6 TTLL5 PARP3 CEP290 TRIM43 C2CD5 DDX11 CEP120 KIF15 DIAPH3 LZTS2 HSPA1A HSPA1B PCNT | 5.35e-06 | 919 | 109 | 17 | GO:0005815 |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 7.58e-06 | 8 | 109 | 3 | GO:0071144 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DDX12P GCFC2 RBBP8 SYNE1 SF3A1 UBA2 XRCC5 DDX11 RANBP17 RANBP3L SYNE2 SUN3 PRKDC DSCC1 HSPA1A HSPA1B ANAPC5 SMAD1 SMAD3 SMAD5 RAD23B | 7.60e-06 | 1377 | 109 | 21 | GO:0140513 |
| GeneOntologyCellularComponent | SMAD protein complex | 1.61e-05 | 10 | 109 | 3 | GO:0071141 | |
| GeneOntologyCellularComponent | Ctf18 RFC-like complex | 1.61e-05 | 10 | 109 | 3 | GO:0031390 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT1 KRT2 KIF23 EFCAB6 DYNC2H1 TTLL5 KIF16B NARF DST KIF15 KRT77 RP1 DIAPH3 LZTS2 DNAH6 PCNT | 1.68e-05 | 899 | 109 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule associated complex | 2.18e-05 | 161 | 109 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 2.21e-05 | 11 | 109 | 3 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 2.21e-05 | 11 | 109 | 3 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 2.21e-05 | 11 | 109 | 3 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 2.21e-05 | 11 | 109 | 3 | GO:0034993 | |
| GeneOntologyCellularComponent | focal adhesion | RPL22 KIF23 ITGA5 RSU1 DST SYNE2 FLRT2 HSPA1A HSPA1B ATP6V0A2 | 8.66e-05 | 431 | 109 | 10 | GO:0005925 |
| GeneOntologyCellularComponent | microtubule | KIF23 EFCAB6 DYNC2H1 TTLL5 KIF16B DST KIF15 RP1 LZTS2 DNAH6 PCNT | 1.08e-04 | 533 | 109 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | cell-substrate junction | RPL22 KIF23 ITGA5 RSU1 DST SYNE2 FLRT2 HSPA1A HSPA1B ATP6V0A2 | 1.09e-04 | 443 | 109 | 10 | GO:0030055 |
| GeneOntologyCellularComponent | DNA repair complex | 2.26e-04 | 23 | 109 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase complex | 2.67e-04 | 5 | 109 | 2 | GO:0070418 | |
| GeneOntologyCellularComponent | centriole | 2.86e-04 | 172 | 109 | 6 | GO:0005814 | |
| GeneOntologyCellularComponent | cell leading edge | 2.88e-04 | 500 | 109 | 10 | GO:0031252 | |
| GeneOntologyCellularComponent | NLRP1 inflammasome complex | 3.99e-04 | 6 | 109 | 2 | GO:0072558 | |
| GeneOntologyCellularComponent | mitotic cohesin complex | 5.56e-04 | 7 | 109 | 2 | GO:0030892 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase-DNA ligase 4 complex | 5.56e-04 | 7 | 109 | 2 | GO:0005958 | |
| GeneOntologyCellularComponent | nuclear envelope | SYNE1 CC2D1B RANBP17 DST CLCA2 RANBP3L SYNE2 SUN3 SMAD1 SMAD3 | 6.97e-04 | 560 | 109 | 10 | GO:0005635 |
| GeneOntologyCellularComponent | spindle | 8.08e-04 | 471 | 109 | 9 | GO:0005819 | |
| GeneOntologyCellularComponent | nonhomologous end joining complex | 9.47e-04 | 9 | 109 | 2 | GO:0070419 | |
| GeneOntologyCellularComponent | cohesin complex | 1.44e-03 | 11 | 109 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | anchoring junction | RPL22 KIF23 MYO1E PSG1 ITGA5 RSU1 DST CLCA2 SYNE2 FLRT2 HSPA1A HSPA1B ATP6V0A2 | 1.71e-03 | 976 | 109 | 13 | GO:0070161 |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 2.01e-03 | 48 | 109 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | kinesin complex | 2.13e-03 | 49 | 109 | 3 | GO:0005871 | |
| GeneOntologyCellularComponent | basal plasma membrane | 2.56e-03 | 354 | 109 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 2.58e-03 | 263 | 109 | 6 | GO:0045111 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.81e-03 | 360 | 109 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | myofibril | 3.10e-03 | 273 | 109 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ABCA13 KIF16B CC2D1B APOB DTX3L GRIN2A ITGAM C2CD5 COLEC12 SNX14 CADPS SNX25 DIAPH3 SNX2 ATP6V0A2 | 3.21e-03 | 1307 | 109 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | nuclear inner membrane | 3.63e-03 | 59 | 109 | 3 | GO:0005637 | |
| GeneOntologyCellularComponent | myosin complex | 3.63e-03 | 59 | 109 | 3 | GO:0016459 | |
| GeneOntologyCellularComponent | vesicle membrane | ABCA13 KIF16B CC2D1B APOB DTX3L GRIN2A ITGAM C2CD5 COLEC12 SNX14 CADPS SNX25 DIAPH3 SNX2 ATP6V0A2 | 3.64e-03 | 1325 | 109 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | basal part of cell | 3.68e-03 | 378 | 109 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | canonical inflammasome complex | 3.90e-03 | 18 | 109 | 2 | GO:0061702 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.16e-03 | 290 | 109 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | endosome membrane | 4.26e-03 | 602 | 109 | 9 | GO:0010008 | |
| GeneOntologyCellularComponent | spindle pole | 4.43e-03 | 205 | 109 | 5 | GO:0000922 | |
| GeneOntologyCellularComponent | centriolar satellite | 4.55e-03 | 128 | 109 | 4 | GO:0034451 | |
| GeneOntologyCellularComponent | axoneme | 4.61e-03 | 207 | 109 | 5 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 4.71e-03 | 208 | 109 | 5 | GO:0097014 | |
| GeneOntologyCellularComponent | leading edge membrane | 4.90e-03 | 210 | 109 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | cornified envelope | 5.63e-03 | 69 | 109 | 3 | GO:0001533 | |
| GeneOntologyCellularComponent | site of DNA damage | 5.78e-03 | 137 | 109 | 4 | GO:0090734 | |
| GeneOntologyCellularComponent | midbody | 6.18e-03 | 222 | 109 | 5 | GO:0030496 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 6.37e-03 | 317 | 109 | 6 | GO:0032838 | |
| Domain | Spectrin_repeat | 6.26e-07 | 29 | 108 | 5 | IPR002017 | |
| Domain | SPEC | 1.05e-06 | 32 | 108 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.05e-06 | 32 | 108 | 5 | IPR018159 | |
| Domain | Spectrin | 8.60e-06 | 23 | 108 | 4 | PF00435 | |
| Domain | ACTININ_2 | 8.60e-06 | 23 | 108 | 4 | PS00020 | |
| Domain | ACTININ_1 | 8.60e-06 | 23 | 108 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.60e-06 | 23 | 108 | 4 | IPR001589 | |
| Domain | DWB | 1.03e-05 | 8 | 108 | 3 | SM00524 | |
| Domain | MH2 | 1.03e-05 | 8 | 108 | 3 | PS51076 | |
| Domain | MH1 | 1.03e-05 | 8 | 108 | 3 | PS51075 | |
| Domain | - | 1.03e-05 | 8 | 108 | 3 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 1.03e-05 | 8 | 108 | 3 | IPR013019 | |
| Domain | Dwarfin | 1.03e-05 | 8 | 108 | 3 | IPR013790 | |
| Domain | MH2 | 1.03e-05 | 8 | 108 | 3 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 1.03e-05 | 8 | 108 | 3 | IPR001132 | |
| Domain | P-loop_NTPase | ABCA1 KIF23 MYH13 ATRX MYO1E DYNC2H1 ABCA13 KIF16B NLRP1 DDX11 CTPS2 KIF15 N4BP2L2 MYH15 GNAS DNAH6 | 2.87e-05 | 848 | 108 | 16 | IPR027417 |
| Domain | MAD_homology1_Dwarfin-type | 3.98e-05 | 12 | 108 | 3 | IPR003619 | |
| Domain | DWA | 3.98e-05 | 12 | 108 | 3 | SM00523 | |
| Domain | MH1 | 3.98e-05 | 12 | 108 | 3 | PF03165 | |
| Domain | SMAD_dom-like | 9.97e-05 | 16 | 108 | 3 | IPR017855 | |
| Domain | - | 9.97e-05 | 16 | 108 | 3 | 2.60.200.10 | |
| Domain | PX | 1.20e-04 | 44 | 108 | 4 | SM00312 | |
| Domain | PX | 1.83e-04 | 49 | 108 | 4 | PF00787 | |
| Domain | PXA | 1.97e-04 | 4 | 108 | 2 | SM00313 | |
| Domain | KASH | 1.97e-04 | 4 | 108 | 2 | IPR012315 | |
| Domain | KASH | 1.97e-04 | 4 | 108 | 2 | PS51049 | |
| Domain | PXA | 1.97e-04 | 4 | 108 | 2 | PS51207 | |
| Domain | PXA | 1.97e-04 | 4 | 108 | 2 | PF02194 | |
| Domain | KASH | 1.97e-04 | 4 | 108 | 2 | SM01249 | |
| Domain | KASH | 1.97e-04 | 4 | 108 | 2 | PF10541 | |
| Domain | Sorting_nexin_C | 1.97e-04 | 4 | 108 | 2 | IPR013937 | |
| Domain | Phox_assoc | 1.97e-04 | 4 | 108 | 2 | IPR003114 | |
| Domain | Nexin_C | 1.97e-04 | 4 | 108 | 2 | PF08628 | |
| Domain | PX | 1.98e-04 | 50 | 108 | 4 | PS50195 | |
| Domain | - | 2.14e-04 | 51 | 108 | 4 | 3.30.1520.10 | |
| Domain | Phox | 2.31e-04 | 52 | 108 | 4 | IPR001683 | |
| Domain | SMAD_FHA_domain | 2.31e-04 | 52 | 108 | 4 | IPR008984 | |
| Domain | Pentatricopeptide_repeat | 3.06e-04 | 23 | 108 | 3 | IPR002885 | |
| Domain | Keratin_2_head | 3.48e-04 | 24 | 108 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 3.48e-04 | 24 | 108 | 3 | PF16208 | |
| Domain | Keratin_II | 4.44e-04 | 26 | 108 | 3 | IPR003054 | |
| Domain | CH | 5.46e-04 | 65 | 108 | 4 | SM00033 | |
| Domain | CH | 7.23e-04 | 70 | 108 | 4 | PF00307 | |
| Domain | - | 7.63e-04 | 71 | 108 | 4 | 1.10.418.10 | |
| Domain | Prefoldin | 8.04e-04 | 72 | 108 | 4 | IPR009053 | |
| Domain | CH | 8.47e-04 | 73 | 108 | 4 | PS50021 | |
| Domain | CH-domain | 9.37e-04 | 75 | 108 | 4 | IPR001715 | |
| Domain | Myosin_head_motor_dom | 1.37e-03 | 38 | 108 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.37e-03 | 38 | 108 | 3 | PS51456 | |
| Domain | Myosin_head | 1.37e-03 | 38 | 108 | 3 | PF00063 | |
| Domain | MYSc | 1.37e-03 | 38 | 108 | 3 | SM00242 | |
| Domain | Integrin_alpha | 1.76e-03 | 11 | 108 | 2 | PF00357 | |
| Domain | Kinesin-like_fam | 1.96e-03 | 43 | 108 | 3 | IPR027640 | |
| Domain | - | 2.10e-03 | 44 | 108 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 2.10e-03 | 44 | 108 | 3 | PF00225 | |
| Domain | KISc | 2.10e-03 | 44 | 108 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 2.10e-03 | 44 | 108 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 2.10e-03 | 44 | 108 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 2.10e-03 | 44 | 108 | 3 | PS50067 | |
| Domain | ABC_A | 2.11e-03 | 12 | 108 | 2 | IPR026082 | |
| Domain | ubiquitin | 2.53e-03 | 47 | 108 | 3 | PF00240 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.88e-03 | 14 | 108 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.88e-03 | 14 | 108 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.88e-03 | 14 | 108 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.88e-03 | 14 | 108 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.88e-03 | 14 | 108 | 2 | IPR011704 | |
| Domain | MT | 2.88e-03 | 14 | 108 | 2 | PF12777 | |
| Domain | AAA_8 | 2.88e-03 | 14 | 108 | 2 | PF12780 | |
| Domain | AAA_5 | 2.88e-03 | 14 | 108 | 2 | PF07728 | |
| Domain | DHC_fam | 3.31e-03 | 15 | 108 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 3.31e-03 | 15 | 108 | 2 | PF03028 | |
| Domain | Myosin_N | 3.31e-03 | 15 | 108 | 2 | PF02736 | |
| Domain | Dynein_heavy_dom | 3.31e-03 | 15 | 108 | 2 | IPR004273 | |
| Domain | Myosin_N | 3.31e-03 | 15 | 108 | 2 | IPR004009 | |
| Domain | UBIQUITIN_2 | 3.76e-03 | 54 | 108 | 3 | PS50053 | |
| Domain | Integrin_alpha_C_CS | 3.77e-03 | 16 | 108 | 2 | IPR018184 | |
| Domain | HSP70 | 3.77e-03 | 16 | 108 | 2 | PF00012 | |
| Domain | - | ABCA1 ATRX MYO1E DYNC2H1 ABCA13 NLRP1 DDX11 CTPS2 N4BP2L2 GNAS DNAH6 | 3.92e-03 | 746 | 108 | 11 | 3.40.50.300 |
| Domain | HSP70_2 | 4.26e-03 | 17 | 108 | 2 | PS00329 | |
| Domain | HSP70_1 | 4.26e-03 | 17 | 108 | 2 | PS00297 | |
| Domain | HSP70_3 | 4.26e-03 | 17 | 108 | 2 | PS01036 | |
| Domain | Ubiquitin_dom | 4.61e-03 | 58 | 108 | 3 | IPR000626 | |
| Domain | Integrin_alpha-2 | 4.77e-03 | 18 | 108 | 2 | IPR013649 | |
| Domain | Myosin_tail_1 | 4.77e-03 | 18 | 108 | 2 | PF01576 | |
| Domain | Myosin_tail | 4.77e-03 | 18 | 108 | 2 | IPR002928 | |
| Domain | INTEGRIN_ALPHA | 4.77e-03 | 18 | 108 | 2 | PS00242 | |
| Domain | Integrin_alpha2 | 4.77e-03 | 18 | 108 | 2 | PF08441 | |
| Domain | Integrin_alpha | 4.77e-03 | 18 | 108 | 2 | IPR000413 | |
| Domain | Hsp_70_fam | 4.77e-03 | 18 | 108 | 2 | IPR013126 | |
| Domain | Int_alpha | 5.31e-03 | 19 | 108 | 2 | SM00191 | |
| Domain | Myosin-like_IQ_dom | 5.31e-03 | 19 | 108 | 2 | IPR027401 | |
| Domain | - | 5.31e-03 | 19 | 108 | 2 | 4.10.270.10 | |
| Domain | Int_alpha_beta-p | 5.31e-03 | 19 | 108 | 2 | IPR013519 | |
| Pubmed | RPL22 KRT1 KRT2 MYH13 ATRX RBBP8 DTNB SYNE1 CC2D1B TRIM43 APOB XRCC5 DDX11 TRIM43B DST SACS SNX25 KRT77 SYNE2 MYH15 PRKDC DIAPH3 ZBTB11 DNAH6 PCNT | 3.42e-12 | 1442 | 111 | 25 | 35575683 | |
| Pubmed | RPL22 KRT1 KRT2 ATRX RBBP6 ABCA13 RBBP8 SF3A1 APOB XRCC5 SGO2 DCLRE1A PRKDC GNAS HSPA1A | 2.74e-09 | 652 | 111 | 15 | 31180492 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KRT1 ATRX RBBP6 DYNC2H1 RBBP8 UBA2 DDX11 KIF15 DIAPH3 GNAS LZTS2 DSCC1 TP53BP1 PCNT | 6.25e-09 | 588 | 111 | 14 | 38580884 |
| Pubmed | 9.76e-09 | 187 | 111 | 9 | 26460568 | ||
| Pubmed | 2.81e-08 | 284 | 111 | 10 | 29459677 | ||
| Pubmed | ATRX DYNC2H1 SYNE1 SF3A1 TTLL5 KIF16B XRCC5 RSU1 C2CD5 SACS SYNE2 DIAPH3 GNAS LZTS2 HSPA1A HSPA1B SNX2 TP53BP1 ATP6V0A2 PCNT | 4.79e-08 | 1487 | 111 | 20 | 33957083 | |
| Pubmed | 9.60e-08 | 14 | 111 | 4 | 26586223 | ||
| Pubmed | 1.18e-07 | 179 | 111 | 8 | 19074885 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 19247629 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 25755279 | ||
| Pubmed | KRT2 SLK KIF23 DCUN1D5 RBBP6 GOLM1 APOB ITGA5 XRCC5 DST LOXL2 SYNE2 PRKDC DIAPH3 GNAS HSPA1B CNOT1 TP53BP1 | 1.55e-07 | 1297 | 111 | 18 | 33545068 | |
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 15647271 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 27137183 | ||
| Pubmed | The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoter. | 3.15e-07 | 5 | 111 | 3 | 17251190 | |
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 19819941 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 25141865 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 8673135 | ||
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 5.26e-07 | 92 | 111 | 6 | 15840729 | |
| Pubmed | Control of early fate decisions in human ES cells by distinct states of TGFbeta pathway activity. | 6.28e-07 | 6 | 111 | 3 | 18393632 | |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 10400677 | ||
| Pubmed | Smad7 is required for the development and function of the heart. | 6.28e-07 | 6 | 111 | 3 | 18952608 | |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 11527400 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 11169847 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 11850197 | ||
| Pubmed | 6.30e-07 | 305 | 111 | 9 | 33194618 | ||
| Pubmed | RPL22 KRT1 KRT2 SLK MYO1E SYNE1 GRIN2A PPFIA3 DST SACS CADPS MTERF2 HSPA1A HSPA1B DNAH6 CNOT1 HOMER1 SNX2 | 6.47e-07 | 1431 | 111 | 18 | 37142655 | |
| Pubmed | ATRX MYO1E SYNE1 TTLL5 CEP290 ADGRB3 REV3L DST SACS CADPS N4BP2L2 PRKDC ZBTB11 HSPA1A HSPA1B PCNT RAD23B | 6.90e-07 | 1285 | 111 | 17 | 35914814 | |
| Pubmed | Neural crest cell-autonomous roles of fibronectin in cardiovascular development. | 9.94e-07 | 24 | 111 | 4 | 26552887 | |
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 15009097 | ||
| Pubmed | Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. | 1.10e-06 | 7 | 111 | 3 | 14699069 | |
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 10376010 | ||
| Pubmed | Negative regulation of BMP/Smad signaling by Tob in osteoblasts. | 1.10e-06 | 7 | 111 | 3 | 11163184 | |
| Pubmed | CtIP-mediated resection is essential for viability and can operate independently of BRCA1. | 1.10e-06 | 7 | 111 | 3 | 24842372 | |
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 15150273 | ||
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 12370310 | ||
| Pubmed | Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. | 1.10e-06 | 7 | 111 | 3 | 14580334 | |
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 23933588 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KIF23 GCFC2 ATRX RBBP6 RBBP8 SF3A1 UBA2 C2CD5 SCAF11 PRKDC ANAPC5 SNX2 TP53BP1 | 1.20e-06 | 774 | 111 | 13 | 15302935 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.27e-06 | 332 | 111 | 9 | 32786267 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SLK MYH13 ATRX DTNB SF3A1 RSU1 C2CD5 DST MYH15 LZTS2 HSPA1A HSPA1B ANAPC5 RAD23B | 1.28e-06 | 910 | 111 | 14 | 36736316 |
| Pubmed | A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. | 1.75e-06 | 8 | 111 | 3 | 19211612 | |
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 10647776 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 12714599 | ||
| Pubmed | Enhanced BMP signaling through ALK2 attenuates keratinocyte differentiation. | 1.75e-06 | 8 | 111 | 3 | 36116371 | |
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 10531362 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 23804438 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 11278251 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 10708949 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL22 KRT1 KIF23 MYO1E RBBP6 SYNE1 SF3A1 APOB XRCC5 DST PRKDC GNAS HSPA1A HSPA1B | 2.09e-06 | 949 | 111 | 14 | 36574265 |
| Pubmed | SLK KIF23 SYNE1 ADGRB3 GRIN2A PPFIA3 XRCC5 DST KIF15 SYNE2 CNOT1 HOMER1 TP53BP1 PCNT | 2.47e-06 | 963 | 111 | 14 | 28671696 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL22 KRT1 KRT2 KIF23 MYO1E RBBP6 SF3A1 OAS3 XRCC5 DST KRT77 SCAF11 PRKDC GNAS LZTS2 HSPA1B | 2.49e-06 | 1257 | 111 | 16 | 36526897 |
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 2.62e-06 | 9 | 111 | 3 | 24932701 | |
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 19018011 | ||
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 9759503 | ||
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 30134160 | ||
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 24816837 | ||
| Pubmed | Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling. | 2.62e-06 | 9 | 111 | 3 | 25155999 | |
| Pubmed | Pellino1 specifically binds to phospho-Thr18 of p53 and is recruited to sites of DNA damage. | 2.62e-06 | 9 | 111 | 3 | 30987826 | |
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 10708948 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL22 SLK KIF23 ATRX DYNC2H1 SYNE1 SF3A1 APOB XRCC5 CLCA2 SGO2 PRKDC GNAS HSPA1A CNOT1 SNX2 RAD23B | 2.80e-06 | 1425 | 111 | 17 | 30948266 |
| Pubmed | TGF-β signaling inhibits canonical BMP signaling pathway during palate development. | 3.74e-06 | 10 | 111 | 3 | 29247325 | |
| Pubmed | 3.74e-06 | 10 | 111 | 3 | 23620745 | ||
| Pubmed | 3.74e-06 | 10 | 111 | 3 | 15221015 | ||
| Pubmed | Protein Arginine Methyltransferase PRMT1 Is Essential for Palatogenesis. | 3.74e-06 | 10 | 111 | 3 | 29986157 | |
| Pubmed | TGFβ pathway is required for viable gestation of Fanconi anemia embryos. | 3.74e-06 | 10 | 111 | 3 | 36441774 | |
| Pubmed | Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. | 3.74e-06 | 10 | 111 | 3 | 12543979 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL22 KRT1 KRT2 SLK SF3A1 UBA2 XRCC5 DST PRKDC GNAS HSPA1A CNOT1 HOMER1 SNX2 RAD23B | 3.91e-06 | 1149 | 111 | 15 | 35446349 |
| Pubmed | 4.03e-06 | 286 | 111 | 8 | 32041737 | ||
| Pubmed | 4.10e-06 | 202 | 111 | 7 | 24639526 | ||
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 4.13e-06 | 287 | 111 | 8 | 36180891 | |
| Pubmed | 4.23e-06 | 34 | 111 | 4 | 26120030 | ||
| Pubmed | 4.35e-06 | 289 | 111 | 8 | 37132043 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL22 SYNE1 SF3A1 CEP290 XRCC5 DST SACS KRT77 SYNE2 PRKDC GNAS CNOT1 SNX2 PCNT | 5.00e-06 | 1024 | 111 | 14 | 24711643 |
| Pubmed | Mechanical feedback defines organizing centers to drive digit emergence. | 5.12e-06 | 11 | 111 | 3 | 35413235 | |
| Pubmed | Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. | 5.12e-06 | 11 | 111 | 3 | 16400328 | |
| Pubmed | Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate. | 5.12e-06 | 11 | 111 | 3 | 27741240 | |
| Pubmed | 5.12e-06 | 11 | 111 | 3 | 24008158 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 5.13e-06 | 394 | 111 | 9 | 27248496 | |
| Pubmed | 6.82e-06 | 12 | 111 | 3 | 21538804 | ||
| Pubmed | Sostdc1 defines the size and number of skin appendage placodes. | 6.82e-06 | 12 | 111 | 3 | 22509524 | |
| Pubmed | 6.82e-06 | 12 | 111 | 3 | 14656760 | ||
| Pubmed | 6.82e-06 | 12 | 111 | 3 | 17460146 | ||
| Pubmed | KIF23 SF3A1 XRCC5 DST SYNE2 SCAF11 PRKDC ZBTB11 CNOT1 TP53BP1 PCNT | 8.15e-06 | 653 | 111 | 11 | 22586326 | |
| Pubmed | 8.24e-06 | 418 | 111 | 9 | 34709266 | ||
| Pubmed | 8.29e-06 | 225 | 111 | 7 | 12168954 | ||
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 8.57e-06 | 86 | 111 | 5 | 10862698 | |
| Pubmed | Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. | 8.84e-06 | 13 | 111 | 3 | 16959237 | |
| Pubmed | Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. | 8.84e-06 | 13 | 111 | 3 | 18329379 | |
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 8.84e-06 | 13 | 111 | 3 | 17920017 | |
| Pubmed | Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. | 8.84e-06 | 13 | 111 | 3 | 19914168 | |
| Pubmed | 8.84e-06 | 13 | 111 | 3 | 17158748 | ||
| Pubmed | Endoglin is required for myogenic differentiation potential of neural crest stem cells. | 8.84e-06 | 13 | 111 | 3 | 17628518 | |
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 1.01e-05 | 2 | 111 | 2 | 12411538 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 2868009 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 1.01e-05 | 2 | 111 | 2 | 24328534 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 3786141 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 1.01e-05 | 2 | 111 | 2 | 26923070 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 16482515 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 11792814 | ||
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 1.01e-05 | 2 | 111 | 2 | 11864979 | |
| Interaction | TRIM37 interactions | RPL22 KRT1 KRT2 KIF23 MYH13 MYO1E RBBP6 DTNB TTLL5 XRCC5 DCLRE1A PRKDC DIAPH3 GNAS LZTS2 HSPA1B | 3.15e-07 | 630 | 110 | 16 | int:TRIM37 |
| Interaction | NINL interactions | RPL22 KRT1 DYNC2H1 TTLL5 CEP290 XRCC5 DCP1B PRKDC DIAPH3 LZTS2 HSPA1B CNOT1 PCNT | 1.30e-06 | 458 | 110 | 13 | int:NINL |
| Interaction | ZUP1 interactions | 5.09e-06 | 174 | 110 | 8 | int:ZUP1 | |
| Interaction | ANAPC2 interactions | 5.52e-06 | 234 | 110 | 9 | int:ANAPC2 | |
| Interaction | MED4 interactions | SLK TTLL5 CEP290 PPFIA3 DST CEP120 CNOT1 HOMER1 SMAD1 TP53BP1 SMAD3 PCNT | 6.46e-06 | 450 | 110 | 12 | int:MED4 |
| Interaction | GAN interactions | 1.04e-05 | 253 | 110 | 9 | int:GAN | |
| Interaction | DMD interactions | 1.23e-05 | 141 | 110 | 7 | int:DMD | |
| Interaction | SPTAN1 interactions | KIF23 MYO1E APOB GRIN2A SPTBN5 CTPS2 DST SYNE2 LZTS2 DNAH6 HOMER1 PCNT | 1.71e-05 | 496 | 110 | 12 | int:SPTAN1 |
| Interaction | MZT1 interactions | 2.06e-05 | 61 | 110 | 5 | int:MZT1 | |
| Interaction | NAA11 interactions | 2.23e-05 | 62 | 110 | 5 | int:NAA11 | |
| Interaction | KRT19 interactions | 2.45e-05 | 282 | 110 | 9 | int:KRT19 | |
| Interaction | CCT8L2 interactions | 2.48e-05 | 157 | 110 | 7 | int:CCT8L2 | |
| Interaction | CEP72 interactions | 2.66e-05 | 107 | 110 | 6 | int:CEP72 | |
| Interaction | PELI1 interactions | 2.81e-05 | 65 | 110 | 5 | int:PELI1 | |
| Interaction | EIF4ENIF1 interactions | 3.97e-05 | 300 | 110 | 9 | int:EIF4ENIF1 | |
| Interaction | TGM2 interactions | 4.47e-05 | 235 | 110 | 8 | int:TGM2 | |
| Interaction | KAT2A interactions | 5.92e-05 | 180 | 110 | 7 | int:KAT2A | |
| Interaction | THRB interactions | 7.28e-05 | 186 | 110 | 7 | int:THRB | |
| Interaction | TOB1 interactions | 9.64e-05 | 44 | 110 | 4 | int:TOB1 | |
| Interaction | DNAJC7 interactions | DYNC2H1 TTLL5 C2CD5 SACS PRKDC GNAS HSPA1A HSPA1B TP53BP1 PCNT | 1.12e-04 | 425 | 110 | 10 | int:DNAJC7 |
| Interaction | HMGA2 interactions | 1.20e-04 | 140 | 110 | 6 | int:HMGA2 | |
| Interaction | KRT8 interactions | 1.52e-04 | 441 | 110 | 10 | int:KRT8 | |
| Interaction | CALM1 interactions | RPL22 KIF23 ATRX MYO1E CEP290 DST SYNE2 SCAF11 GNAS HOMER1 PCNT RAD23B | 1.59e-04 | 626 | 110 | 12 | int:CALM1 |
| Interaction | MPHOSPH9 interactions | 1.73e-04 | 95 | 110 | 5 | int:MPHOSPH9 | |
| Interaction | CSPP1 interactions | 1.82e-04 | 96 | 110 | 5 | int:CSPP1 | |
| Interaction | SMAD9 interactions | 1.94e-04 | 153 | 110 | 6 | int:SMAD9 | |
| Cytoband | 12q13.13 | 5.89e-04 | 67 | 111 | 3 | 12q13.13 | |
| Cytoband | 12q24.31 | 9.87e-04 | 80 | 111 | 3 | 12q24.31 | |
| Cytoband | 7p12.3 | 1.30e-03 | 22 | 111 | 2 | 7p12.3 | |
| Cytoband | 2q11.1 | 2.10e-03 | 28 | 111 | 2 | 2q11.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 2.27e-03 | 107 | 111 | 3 | chr11q22 | |
| GeneFamily | SMAD family | 4.10e-06 | 8 | 77 | 3 | 750 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.07e-04 | 4 | 77 | 2 | 1252 | |
| GeneFamily | Keratins, type II | 2.02e-04 | 27 | 77 | 3 | 609 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 2.51e-04 | 29 | 77 | 3 | 754 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 9.88e-04 | 46 | 77 | 3 | 622 | |
| GeneFamily | ATP binding cassette subfamily A | 1.58e-03 | 14 | 77 | 2 | 805 | |
| GeneFamily | Myosin heavy chains | 1.81e-03 | 15 | 77 | 2 | 1098 | |
| GeneFamily | Heat shock 70kDa proteins | 2.34e-03 | 17 | 77 | 2 | 583 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.62e-03 | 18 | 77 | 2 | 1160 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SLK KIF23 ATRX REV3L C2CD5 DST SACS SYNE2 N4BP2L2 FLRT2 ZBTB11 HOMER1 SNX2 TP53BP1 SMAD3 PCNT RAD23B | 1.20e-07 | 856 | 111 | 17 | M4500 |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 6.13e-07 | 230 | 111 | 9 | M11563 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SLK KIF23 RBBP8 CEP290 KIF16B REV3L KIF15 SACS SYNE2 N4BP2L2 SCAF11 DIAPH3 ZBTB11 SNX2 | 7.42e-07 | 656 | 111 | 14 | M18979 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 3.69e-05 | 478 | 111 | 10 | M45785 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.27e-05 | 300 | 111 | 8 | M8702 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_2WK | 5.13e-05 | 48 | 111 | 4 | M8645 | |
| Coexpression | FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS | 5.50e-05 | 311 | 111 | 8 | M61 | |
| Coexpression | SAFFORD_T_LYMPHOCYTE_ANERGY | 5.88e-05 | 97 | 111 | 5 | MM692 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_2WK | 6.04e-05 | 50 | 111 | 4 | MM663 | |
| Coexpression | LAMB_CCND1_TARGETS | 8.00e-05 | 20 | 111 | 3 | M2935 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | KIF23 EFCAB6 ATRX RBBP8 CEP290 DST KIF15 SGO2 SCAF11 PRKDC DSCC1 CNOT1 HOMER1 | 6.93e-07 | 469 | 107 | 13 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_500 | 3.86e-05 | 75 | 107 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k1 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.35e-08 | 187 | 111 | 8 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.25e-08 | 195 | 111 | 8 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-07 | 169 | 111 | 7 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-07 | 178 | 111 | 7 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-07 | 178 | 111 | 7 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-07 | 181 | 111 | 7 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-07 | 181 | 111 | 7 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 4.20e-07 | 185 | 111 | 7 | 912d8efdc37820dbb07736221a98af929e5a7c97 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.78e-07 | 194 | 111 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-07 | 195 | 111 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.41e-07 | 197 | 111 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.63e-07 | 198 | 111 | 7 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.86e-07 | 199 | 111 | 7 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 6.86e-07 | 199 | 111 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.86e-07 | 199 | 111 | 7 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.86e-07 | 199 | 111 | 7 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.86e-07 | 199 | 111 | 7 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.09e-07 | 200 | 111 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.09e-07 | 200 | 111 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-06 | 163 | 111 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-06 | 169 | 111 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-06 | 171 | 111 | 6 | e3cab55f39879e2bd3e8bda91802181075839bc4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-06 | 171 | 111 | 6 | 52fdc2a4ec36fb91583b1215362548ceb6740ae1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.97e-06 | 174 | 111 | 6 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 4.97e-06 | 174 | 111 | 6 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-06 | 178 | 111 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.03e-06 | 180 | 111 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-06 | 181 | 111 | 6 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | IIH-cycling-|IIH / Condition, Cell_class and T cell subcluster | 6.22e-06 | 181 | 111 | 6 | 7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078 | |
| ToppCell | IIH-cycling|IIH / Condition, Cell_class and T cell subcluster | 6.22e-06 | 181 | 111 | 6 | ec3e782ce93dcfe1a54fb7284e4e39063614b0e2 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-06 | 182 | 111 | 6 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-06 | 182 | 111 | 6 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.63e-06 | 183 | 111 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.63e-06 | 183 | 111 | 6 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.73e-06 | 188 | 111 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.73e-06 | 188 | 111 | 6 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 189 | 111 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 189 | 111 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.97e-06 | 189 | 111 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-06 | 190 | 111 | 6 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.21e-06 | 190 | 111 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 191 | 111 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.46e-06 | 191 | 111 | 6 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 8.46e-06 | 191 | 111 | 6 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.46e-06 | 191 | 111 | 6 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 191 | 111 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 191 | 111 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 8.98e-06 | 193 | 111 | 6 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 193 | 111 | 6 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 193 | 111 | 6 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.25e-06 | 194 | 111 | 6 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.25e-06 | 194 | 111 | 6 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.25e-06 | 194 | 111 | 6 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.25e-06 | 194 | 111 | 6 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.25e-06 | 194 | 111 | 6 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.25e-06 | 194 | 111 | 6 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.25e-06 | 194 | 111 | 6 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.52e-06 | 195 | 111 | 6 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 9.52e-06 | 195 | 111 | 6 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-06 | 195 | 111 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 9.80e-06 | 196 | 111 | 6 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.80e-06 | 196 | 111 | 6 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.80e-06 | 196 | 111 | 6 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.01e-05 | 197 | 111 | 6 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 197 | 111 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-05 | 197 | 111 | 6 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-05 | 197 | 111 | 6 | 196eaecef7003ed83f323c1f157c6a3594650097 | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 1.01e-05 | 197 | 111 | 6 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | (4)_B_cells-(4)_B_Hypermutation|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.04e-05 | 198 | 111 | 6 | 8be724a49b4c911d68c3e82fb75e96722d0eaa03 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.04e-05 | 198 | 111 | 6 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.04e-05 | 198 | 111 | 6 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.04e-05 | 198 | 111 | 6 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 1.04e-05 | 198 | 111 | 6 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-05 | 198 | 111 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.04e-05 | 198 | 111 | 6 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.04e-05 | 198 | 111 | 6 | 47d572b9db2843aeb2079f33a852babf67270be4 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.04e-05 | 198 | 111 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-05 | 198 | 111 | 6 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | (1)_T_cell_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.04e-05 | 198 | 111 | 6 | dac3a16e3a070a37f4d0ea37633c23fdc8a9c70a | |
| ToppCell | (0)_NK_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.04e-05 | 198 | 111 | 6 | c5336d9b802393d6fd6f8446ea4bb6befeb97bfd | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 198 | 111 | 6 | bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86 | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.04e-05 | 198 | 111 | 6 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | severe_influenza-T/NK_proliferative|severe_influenza / disease group, cell group and cell class (v2) | 1.07e-05 | 199 | 111 | 6 | 638b1491c47f2884daf1c1d38a779ad8e0f59c52 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.07e-05 | 199 | 111 | 6 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 1.07e-05 | 199 | 111 | 6 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 1.07e-05 | 199 | 111 | 6 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | severe_influenza-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.07e-05 | 199 | 111 | 6 | 1541f655f7d12c650added3683d07e5417a68dfb | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 199 | 111 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.07e-05 | 199 | 111 | 6 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.07e-05 | 199 | 111 | 6 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 1.07e-05 | 199 | 111 | 6 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.07e-05 | 199 | 111 | 6 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 1.07e-05 | 199 | 111 | 6 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / disease group, cell group and cell class | 1.07e-05 | 199 | 111 | 6 | af78837f3a7641a5bd98765eef9cb4f86034048c | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.07e-05 | 199 | 111 | 6 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 1.07e-05 | 199 | 111 | 6 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 1.07e-05 | 199 | 111 | 6 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | (1)_T_cells-(1)_T_cell_dividing|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.07e-05 | 199 | 111 | 6 | 33afdd1b1b951b360ababf440bc556fd9e1c1db2 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.07e-05 | 199 | 111 | 6 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-05 | 200 | 111 | 6 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| Computational | Neighborhood of REV3L | 4.96e-05 | 58 | 75 | 5 | MORF_REV3L | |
| Drug | CPG-oligonucleotide | 3.01e-07 | 184 | 111 | 9 | ctd:C408982 | |
| Disease | Colorectal Carcinoma | ABCA1 CACUL1 ABCA13 SYNE1 SF3A1 APOB GRIN2A SACS CCDC62 GNAS LZTS2 SMAD3 | 1.04e-05 | 702 | 108 | 12 | C0009402 |
| Disease | SECKEL SYNDROME 2 | 1.33e-05 | 2 | 108 | 2 | C1847572 | |
| Disease | cinnamaldehyde measurement | 1.33e-05 | 2 | 108 | 2 | EFO_0021839 | |
| Disease | triglycerides in large LDL measurement | 1.88e-05 | 43 | 108 | 4 | EFO_0022319 | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 3.97e-05 | 3 | 108 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | triglycerides in LDL measurement | 5.38e-05 | 56 | 108 | 4 | EFO_0022320 | |
| Disease | factor VIII measurement, coronary artery disease | 6.14e-05 | 113 | 108 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | Withdrawal Symptoms | 6.18e-05 | 58 | 108 | 4 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 6.18e-05 | 58 | 108 | 4 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 6.18e-05 | 58 | 108 | 4 | C0038587 | |
| Disease | sphingomyelin measurement | 7.57e-05 | 278 | 108 | 7 | EFO_0010118 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 7.93e-05 | 4 | 108 | 2 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.32e-04 | 5 | 108 | 2 | C1450051 | |
| Disease | Cerebellar Ataxia | 1.32e-04 | 5 | 108 | 2 | C0007758 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.32e-04 | 5 | 108 | 2 | C0410190 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 1.32e-04 | 5 | 108 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.92e-04 | 144 | 108 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.97e-04 | 6 | 108 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.97e-04 | 6 | 108 | 2 | C0410189 | |
| Disease | coronary artery calcification | 2.56e-04 | 450 | 108 | 8 | EFO_0004723 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.75e-04 | 7 | 108 | 2 | C0751337 | |
| Disease | myocardial infarction | 3.11e-04 | 350 | 108 | 7 | EFO_0000612 | |
| Disease | marginal zone B-cell lymphoma | 3.66e-04 | 8 | 108 | 2 | EFO_1000630 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 3.66e-04 | 8 | 108 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | Hypercholesterolemia | 3.96e-04 | 39 | 108 | 3 | C0020443 | |
| Disease | Schizophrenia | ABCA1 ABCA13 GRIN2A ITGAM GNAS HSPA1A HSPA1B IL3 HOMER1 SMAD5 PCNT | 3.99e-04 | 883 | 108 | 11 | C0036341 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 4.33e-04 | 264 | 108 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | Major depression, single episode | 4.70e-04 | 9 | 108 | 2 | C0024517 | |
| Disease | alcohol dependence (implicated_via_orthology) | 4.70e-04 | 9 | 108 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 5.57e-04 | 277 | 108 | 6 | C0009404 | |
| Disease | BMI-adjusted waist-hip ratio, asthma | 5.86e-04 | 10 | 108 | 2 | EFO_0007788, MONDO_0004979 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 5.86e-04 | 10 | 108 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | cardiovascular system disease (is_marker_for) | 5.86e-04 | 10 | 108 | 2 | DOID:1287 (is_marker_for) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 5.86e-04 | 10 | 108 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 5.86e-04 | 10 | 108 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 5.86e-04 | 10 | 108 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 5.86e-04 | 10 | 108 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 5.86e-04 | 10 | 108 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 5.86e-04 | 10 | 108 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 5.86e-04 | 10 | 108 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | saturated fatty acids measurement | 6.05e-04 | 45 | 108 | 3 | EFO_0022304 | |
| Disease | Jeune thoracic dystrophy | 7.14e-04 | 11 | 108 | 2 | C0265275 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 7.21e-04 | 291 | 108 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | coronary artery disease, factor VII measurement | 7.52e-04 | 111 | 108 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 7.52e-04 | 111 | 108 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 8.55e-04 | 12 | 108 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 8.55e-04 | 12 | 108 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 8.55e-04 | 12 | 108 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | factor XI measurement, coronary artery disease | 8.59e-04 | 115 | 108 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | Cocaine-Related Disorders | 9.16e-04 | 117 | 108 | 4 | C0236736 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 9.45e-04 | 118 | 108 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | triglycerides in HDL measurement | 9.78e-04 | 53 | 108 | 3 | EFO_0022317 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.01e-03 | 13 | 108 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.01e-03 | 13 | 108 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Short Rib-Polydactyly Syndrome | 1.01e-03 | 13 | 108 | 2 | C0036996 | |
| Disease | smoking status measurement, ulcerative colitis | 1.01e-03 | 13 | 108 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | Hyperlipoproteinemia Type IIb | 1.01e-03 | 13 | 108 | 2 | C1704417 | |
| Disease | left ventricular diastolic function measurement | 1.03e-03 | 54 | 108 | 3 | EFO_0008204 | |
| Disease | triglycerides in very large HDL measurement | 1.09e-03 | 55 | 108 | 3 | EFO_0022324 | |
| Disease | Saldino-Noonan Syndrome | 1.17e-03 | 14 | 108 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 1.17e-03 | 14 | 108 | 2 | C0024507 | |
| Disease | Cocaine Abuse | 1.24e-03 | 127 | 108 | 4 | C0009171 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.35e-03 | 15 | 108 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | coronary artery disease | SETD9 ABCA1 SLK NBEAL1 DYNC2H1 APOB CEP120 SHOC1 N4BP2L2 SCAF11 RP1 SMAD3 | 1.42e-03 | 1194 | 108 | 12 | EFO_0001645 |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.45e-03 | 225 | 108 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | Hyperlipoproteinemia Type IIa | 1.54e-03 | 16 | 108 | 2 | C0745103 | |
| Disease | triglycerides in medium LDL measurement | 1.54e-03 | 62 | 108 | 3 | EFO_0022322 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.61e-03 | 63 | 108 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | Cocaine Dependence | 1.73e-03 | 139 | 108 | 4 | C0600427 | |
| Disease | ceramide measurement | 1.76e-03 | 235 | 108 | 5 | EFO_0010222 | |
| Disease | triglycerides in small LDL measurement | 1.77e-03 | 65 | 108 | 3 | EFO_0022323 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.89e-03 | 239 | 108 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.93e-03 | 67 | 108 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | Malignant neoplasm of breast | DYNC2H1 SYNE1 KIF16B DTX3L CLCA2 LOXL2 SYNE2 LZTS2 HSPA1B ANAPC5 TP53BP1 | 1.95e-03 | 1074 | 108 | 11 | C0006142 |
| Disease | Hypercholesterolemia, Familial | 1.95e-03 | 18 | 108 | 2 | C0020445 | |
| Disease | cerebral infarction (is_marker_for) | 2.18e-03 | 19 | 108 | 2 | DOID:3526 (is_marker_for) | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 2.27e-03 | 71 | 108 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | unipolar depression, bipolar disorder | 2.63e-03 | 156 | 108 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | vitiligo (is_implicated_in) | 2.66e-03 | 21 | 108 | 2 | DOID:12306 (is_implicated_in) | |
| Disease | Unipolar Depression | 2.68e-03 | 259 | 108 | 5 | C0041696 | |
| Disease | Seckel syndrome | 2.92e-03 | 22 | 108 | 2 | C0265202 | |
| Disease | interleukin 10 measurement | 2.97e-03 | 78 | 108 | 3 | EFO_0004750 | |
| Disease | schizophrenia (is_implicated_in) | 2.97e-03 | 78 | 108 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | cholesterol in large HDL measurement | 3.19e-03 | 80 | 108 | 3 | EFO_0021900 | |
| Disease | spermatogenic failure (is_implicated_in) | 3.19e-03 | 23 | 108 | 2 | DOID:0111910 (is_implicated_in) | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.29e-03 | 166 | 108 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | HDL cholesterol change measurement | 3.48e-03 | 24 | 108 | 2 | EFO_0007805 | |
| Disease | Carcinoma, Pancreatic Ductal | 3.48e-03 | 24 | 108 | 2 | C0887833 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 3.48e-03 | 24 | 108 | 2 | DOID:1184 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDAQRLEEFFTKNQQ | 51 | Q99708 | |
| LEEFFTKNQQLREQQ | 56 | Q99708 | |
| KQQSDLQFLNFNVEN | 291 | Q6P9F0 | |
| ELFQELNQKFQTLDR | 1436 | O60242 | |
| NELISFKNQSQERLN | 1841 | Q7Z2Y8 | |
| FVLELFTDNKLNNIN | 1786 | O95477 | |
| QEALRNKFVRNFVEN | 3371 | Q86UQ4 | |
| GQINDIFQKLNIFDQ | 66 | Q9Y5C1 | |
| SAILFKLQFEEQVNN | 801 | Q9NSV4 | |
| NQNESNFILVLDAKN | 541 | Q9BYV7 | |
| LQNKFDFLRSQLNDI | 121 | Q9BTE7 | |
| FDNLSNLKQLTARNN | 296 | O43155 | |
| AQDQKFQRELIQNGF | 326 | Q86Y37 | |
| ANANQLQKLQATFEF | 961 | Q96L93 | |
| ENQNQFNLGRLQISK | 2166 | Q6ZS30 | |
| EKNENLAANFLLQQN | 391 | P54727 | |
| VQLFDQNAQNYQKLL | 461 | Q9H2T7 | |
| LQIFNNNFKQEDVKR | 701 | Q9H2T7 | |
| ENNNNKFYIIQLLQD | 76 | Q9Y6F1 | |
| QAEFFLSQQASLLKN | 211 | Q9UJX4 | |
| QQLQTVKDRFQAFLN | 151 | Q9ULU8 | |
| QLQQEKRQLQDDFAQ | 396 | Q9BRK4 | |
| FEIDQLSRNLQNFKK | 876 | Q9NS87 | |
| LLEQNLFEFQKENNF | 91 | Q8NE63 | |
| RQQKLEESSNNLTQF | 4616 | Q03001 | |
| TQNAQARQLLEKEFS | 1091 | O75145 | |
| SFIDKVRFLEQQNQV | 191 | P35908 | |
| FKFDNSLINQIENLN | 166 | Q9Y4K0 | |
| VQKLLQDFFNGRDLN | 346 | P0DMV9 | |
| REQIKSLNNQFASFI | 181 | P04264 | |
| VDLNDFREFVNNNIK | 666 | Q9HCI6 | |
| LLQDESLNIFQNLNK | 641 | P51160 | |
| SLNIFQNLNKRQFET | 646 | P51160 | |
| NEDFNQKFTQLLLLQ | 271 | Q9C000 | |
| RIKNDFQNLQQVFLQ | 236 | Q5KU26 | |
| KTINDFLFQSQIDNI | 476 | Q96FC9 | |
| LQNQFQKELAEQRAE | 376 | O95613 | |
| RLEKSQNEQEAFRNN | 311 | Q86YM7 | |
| QNEQEAFRNNLKTLL | 316 | Q86YM7 | |
| ANKFLRQAVNNFKNE | 311 | Q7Z6E9 | |
| QENQKLNVQFFQELG | 146 | Q49AM1 | |
| IQFDFQILSKNLNNS | 761 | P08648 | |
| VQNASRTQNLFEKLQ | 346 | Q8IZD4 | |
| LFQRALQNKQDSENT | 3526 | Q8NCM8 | |
| TISEQNIQRANLFNK | 336 | P04114 | |
| NSVFENLEQLLQQNK | 281 | P46100 | |
| QALKNFEKVNFERLN | 1346 | Q9C0G6 | |
| NLEAFNRAVKSLQNA | 76 | P08700 | |
| IFQIFNNRNCLSLKD | 291 | P51878 | |
| LLQNAVKFNLAEFQE | 276 | Q9BVC3 | |
| QFLSEQFLESEQKQQ | 186 | Q8TDB6 | |
| QDDFCNIQNILLKFQ | 461 | P16383 | |
| NVFLKNLSINNDLNL | 231 | Q5THR3 | |
| FDRQQNEILNAAQKF | 1421 | O15078 | |
| FQQFKDQQNNKPEIR | 801 | Q8N960 | |
| EQINKNQFFAALLTA | 426 | Q9P278 | |
| SPEFDQLFKLNINRN | 751 | Q5T0F9 | |
| LFQSQIDNINLFKVQ | 501 | Q92771 | |
| LSFNFDANKQQRQLI | 426 | O60941 | |
| NQTNRLQEALNLFKS | 261 | P63092 | |
| LFNLQAVQERFNQNK | 301 | Q8IYD9 | |
| QQALQFTDFVENDKL | 256 | Q6PJP8 | |
| VQKLLQDFFNGRDLN | 346 | P0DMV8 | |
| QDVLQFQKNQTNLER | 136 | Q8NBJ4 | |
| DFNNIQDSENNLLKN | 656 | Q99590 | |
| QNEINRLEKQAFLDQ | 4356 | Q9NZJ4 | |
| SQAQVFELERRFKQQ | 156 | Q8TAU0 | |
| LNLTNQALNKNFNDL | 736 | Q86YS7 | |
| INNLNPRENKDVLNF | 246 | P11464 | |
| QELETQNQKLQRQFS | 591 | Q02241 | |
| EFLQPNRQFLAQVNK | 761 | Q9Y6K5 | |
| IFKAVDENNNLLNNR | 2061 | P56715 | |
| ELKNLEVLNFFNNQI | 61 | Q15404 | |
| FEEKQQQFENLDQQL | 306 | O60749 | |
| LNKEYQEIFQQLQRS | 201 | Q96BQ3 | |
| FLQKEEQRAQQQLNS | 836 | Q9H2G2 | |
| LNQSENAKKDFFRNL | 636 | Q8NF91 | |
| KREQFESVAQLNNSL | 1986 | Q8WXH0 | |
| FSRQKDFQQQQVLEL | 4376 | Q8WXH0 | |
| NQLNKFLQNLLSDER | 596 | Q9H3E2 | |
| EQLCINFTNEKLQQF | 486 | Q9Y2K3 | |
| LDLQNNKLVDNAFQR | 171 | O60938 | |
| QALFLNDFNKQSEIL | 61 | Q8NE22 | |
| SALQNQNQDLFIDDK | 76 | Q5VXU9 | |
| QDNSEVLFLKENNQN | 201 | Q562F6 | |
| TIDVSNLNRQFLFQK | 51 | Q9UBT2 | |
| NNFEALKTIQNQLRE | 316 | P11215 | |
| IRQNEINNPKFNFLN | 71 | Q15459 | |
| KQERLQAEQQEQLFL | 2041 | Q9NRC6 | |
| KIFNNQEFAQLLAQS | 381 | Q99717 | |
| KIFNNQEFAQLLAQS | 381 | Q15797 | |
| KSLQNIQDDFNNAIL | 806 | Q9UQC9 | |
| QEKIAFIFNNLSQSN | 1096 | A5YKK6 | |
| RKDNFQTILSLQQFQ | 571 | Q15735 | |
| RFEVNPNLIKQFEQN | 481 | Q9NRF8 | |
| LKQLNEQRLSNQFCD | 201 | O95625 | |
| FQKRLQEILKQNDFS | 301 | O60673 | |
| KLFNDLFKNNANRAE | 756 | Q9Y5W7 | |
| KIFNNQEFAALLAQS | 341 | P84022 | |
| LVALQSFNKQRDVNQ | 406 | Q86VV4 | |
| KESQNLENNFRQILF | 111 | Q8TAQ9 | |
| EQLCINFTNEKLQQF | 476 | Q9UKX3 | |
| AANFEQFLQERIKVN | 36 | P35268 | |
| NLKVLLVSDQQQNFL | 1871 | Q12888 | |
| NITQKLLQDFNRFLN | 2831 | P78527 | |
| LNKEYQEIFQQLQRS | 201 | A6NCK2 | |
| EVLLEQNAQFRNQAK | 266 | Q96K80 | |
| INLQENQNALKFLAS | 556 | P01266 | |
| DGQLQRFLENQDKLF | 131 | Q96RE9 | |
| YQLQFALQQLEQQKL | 1146 | Q6EMB2 | |
| EEQRFNNFLKALQEK | 651 | P13010 | |
| QFRDLNQNVSSFQRK | 36 | Q9Y487 | |
| ASFIDKVRFLEQQNQ | 176 | Q7Z794 | |
| EQFCINFVNEKLQQI | 401 | Q12965 | |
| VQLSQQNAKDFFRVL | 66 | Q9UHQ1 | |
| RFVNQQFQEEKLNKL | 386 | Q92802 | |
| NELQTFVANRQKDNL | 961 | Q12879 |